DERMNCMHealthcare·Drug Manufacturers - Specialty & Generic#52 in industry

Journey Medical Corporation

Reports in 17d· 2026-05-14

-39.7% · 90d

$5.26

+0.11 (+2.14%)

After-Hours $5.26(+0.00)

News

(1)

April 2026

Apr 21, 20266 days ago8-KHealthcare

DERM secures third GPO deal, expanding Emrosi coverage to 150 million lives

DERMJourney Medical Corp

# 📜 What This Document Is 📄 This document is an 8-K filing, which is an important, timely filing used to announce material events to the public. Think of it like a company issuing an urgent press release through the SEC. It tells investors and the market what happened *today* that could significa

Read summaryView on SEC EDGAR

Key Data

Market Cap$174.9M

Open$5.15

Prev Close$5.15

Day Range$5.02 – $5.32

52W Range$4.31 – $9.55

Volume141,402

P/E (TTM)—

EPS$-0.47

Dividend Yield—

Beta1.04

Profit Margin-18.48%

Revenue Growth18.10%

Price Target$13.25(+151.9%)

Next Earnings2026-05-14(17d)

Analyst Ratings

Strong Buy3 analysts

Buy 3Hold 0Sell 0

About

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Healthcare · Drug Manufacturers - Specialty & Generic

58 employees

journeymedicalcorp.com